CL2011003129A1 - Procedimiento para determinar riesgo de padecer enfermedad cardiovascular que comprende determinar la presencia de polimorfismos de un solo nucleotido (snp) - Google Patents
Procedimiento para determinar riesgo de padecer enfermedad cardiovascular que comprende determinar la presencia de polimorfismos de un solo nucleotido (snp)Info
- Publication number
- CL2011003129A1 CL2011003129A1 CL2011003129A CL2011003129A CL2011003129A1 CL 2011003129 A1 CL2011003129 A1 CL 2011003129A1 CL 2011003129 A CL2011003129 A CL 2011003129A CL 2011003129 A CL2011003129 A CL 2011003129A CL 2011003129 A1 CL2011003129 A1 CL 2011003129A1
- Authority
- CL
- Chile
- Prior art keywords
- suffering
- risk
- procedure
- includes determining
- cardiovascular disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Procedimiento para determinar riesgo de padecer enfermedad cardiovascular que comprende determinar la presencia de polimorfismos de un solo nucleótido (SNP).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09162329.8A EP2264183B1 (en) | 2009-06-09 | 2009-06-09 | Risk markers for cardiovascular disease |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2011003129A1 true CL2011003129A1 (es) | 2012-04-27 |
Family
ID=41061079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2011003129A CL2011003129A1 (es) | 2009-06-09 | 2011-12-09 | Procedimiento para determinar riesgo de padecer enfermedad cardiovascular que comprende determinar la presencia de polimorfismos de un solo nucleotido (snp) |
Country Status (14)
Country | Link |
---|---|
US (1) | US9957565B2 (es) |
EP (2) | EP2264183B1 (es) |
AR (1) | AR077026A1 (es) |
AU (1) | AU2010257482B2 (es) |
BR (1) | BRPI1013082A2 (es) |
CA (1) | CA2764693C (es) |
CL (1) | CL2011003129A1 (es) |
ES (2) | ES2623633T3 (es) |
MX (1) | MX2011013243A (es) |
PE (1) | PE20121029A1 (es) |
PT (2) | PT2264183T (es) |
RU (1) | RU2524659C2 (es) |
UY (1) | UY32698A (es) |
WO (1) | WO2010142713A1 (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10359425B2 (en) | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
EP2591357A4 (en) | 2010-07-09 | 2014-01-01 | Somalogic Inc | BIOMARKER FOR LUNG CANCER AND USE |
AU2011289284B2 (en) | 2010-08-13 | 2015-04-09 | Somalogic Operating Co., Inc. | Pancreatic cancer biomarkers and uses thereof |
EP2554679B1 (en) * | 2011-08-05 | 2016-03-02 | Gendiag.exe, S.L. | Genetic markers for cardiovascular disease risk assessment |
CA2847903C (en) * | 2011-09-30 | 2020-10-27 | Somalogic, Inc. | Cardiovascular risk event prediction and uses thereof |
EP2843056B8 (en) * | 2013-08-30 | 2019-06-26 | GENINCODE UK, Ltd. | Risk markers for cardiovascular disease in patients with chronic kidney disease |
RU2547575C1 (ru) * | 2014-02-06 | 2015-04-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Ярославская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Способ прогнозирования течения хронической сердечной недостаточности |
RU2602451C1 (ru) * | 2015-08-28 | 2016-11-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Красноярский государственный медицинский университет имени профессора В.Ф. Войно-Ясенецкого" Министерства здравоохранения Российской Федерации | Способ диагностики генетической предрасположенности к развитию ишемического инсульта у больных с фибрилляцией предсердий |
US10747899B2 (en) * | 2015-10-07 | 2020-08-18 | The Board Of Trustees Of The Leland Stanford Junior University | Techniques for determining whether an individual is included in ensemble genomic data |
RU2624859C1 (ru) * | 2016-06-15 | 2017-07-07 | Общество с ограниченной ответственностью "Меднорд-Техника" (ООО "Меднорд-Техника") | Способ оценки повышенного риска возникновения флеботромбозов у пациентов с ишемической болезнью сердца |
CN106250524A (zh) * | 2016-08-04 | 2016-12-21 | 浪潮软件集团有限公司 | 一种基于语义信息的机构名抽取方法和装置 |
US10451544B2 (en) | 2016-10-11 | 2019-10-22 | Genotox Laboratories | Methods of characterizing a urine sample |
WO2019191010A1 (en) * | 2018-03-27 | 2019-10-03 | Aardvark Therapeutics Inc. | Personalized treatment method for congestive heart failure |
US11308325B2 (en) * | 2018-10-16 | 2022-04-19 | Duke University | Systems and methods for predicting real-time behavioral risks using everyday images |
CN110229882A (zh) * | 2019-07-03 | 2019-09-13 | 贵州省临床检验中心 | 一种与心血管疾病相关的mthfr基因分子标记及其应用 |
CN110229881A (zh) * | 2019-07-03 | 2019-09-13 | 贵州省临床检验中心 | 一种与成人心血管疾病相关的snp分子标记及其应用 |
CN112210598A (zh) * | 2019-07-11 | 2021-01-12 | 合肥中科普瑞昇生物医药科技有限公司 | 检测高血糖药物代谢相关基因多态性的引物组和试剂盒及它们的应用 |
CN110607360A (zh) * | 2019-09-19 | 2019-12-24 | 华中科技大学同济医学院附属同济医院 | 一种评估慢性心力衰竭预后的引物组、试剂盒及评估慢性心力衰竭预后的方法 |
EP4132653A4 (en) * | 2020-04-11 | 2024-05-22 | Geneticure Inc | GENETIC METHOD FOR DIAGNOSIS AND TREATMENT OF PRE- AND POST-CORONAVIRUS INFECTIONS |
US11978532B2 (en) | 2020-04-30 | 2024-05-07 | Optum Services (Ireland) Limited | Cross-variant polygenic predictive data analysis |
US11574738B2 (en) | 2020-04-30 | 2023-02-07 | Optum Services (Ireland) Limited | Cross-variant polygenic predictive data analysis |
US11610645B2 (en) * | 2020-04-30 | 2023-03-21 | Optum Services (Ireland) Limited | Cross-variant polygenic predictive data analysis |
US11482302B2 (en) | 2020-04-30 | 2022-10-25 | Optum Services (Ireland) Limited | Cross-variant polygenic predictive data analysis |
US11967430B2 (en) | 2020-04-30 | 2024-04-23 | Optum Services (Ireland) Limited | Cross-variant polygenic predictive data analysis |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US723961A (en) | 1902-10-01 | 1903-03-31 | Nelson W Clark | Lady's belt, collar, or the like. |
US4883750A (en) | 1984-12-13 | 1989-11-28 | Applied Biosystems, Inc. | Detection of specific sequences in nucleic acids |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
US5004565A (en) | 1986-07-17 | 1991-04-02 | The Board Of Governors Of Wayne State University | Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes |
US5856522A (en) | 1995-05-04 | 1999-01-05 | Tropix, Inc. | Method of using synthesis of 1,2-dioxetanes and kits therefore |
US5994073A (en) | 1990-08-30 | 1999-11-30 | Tropix, Inc. | Enhancement of chemiluminescent assays |
US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
DE69433180T2 (de) | 1993-10-26 | 2004-06-24 | Affymetrix, Inc., Santa Clara | Felder von nukleinsaeuresonden auf biologischen chips |
US6015880A (en) | 1994-03-16 | 2000-01-18 | California Institute Of Technology | Method and substrate for performing multiple sequential reactions on a matrix |
US5807522A (en) | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
US5773628A (en) | 1994-11-14 | 1998-06-30 | Tropix, Inc. | 1,2-dioxetane compounds with haloalkoxy groups, methods preparation and use |
US5591591A (en) | 1995-02-09 | 1997-01-07 | Tropix, Inc. | Dioxetane compounds for the chemiluminescent detection of proteases, methods of use and kits therefore |
US5589136A (en) | 1995-06-20 | 1996-12-31 | Regents Of The University Of California | Silicon-based sleeve devices for chemical reactions |
US5679803A (en) | 1995-10-25 | 1997-10-21 | Tropix, Inc. | 1,2 chemiluminescent dioxetanes of improved performance |
US5885470A (en) | 1997-04-14 | 1999-03-23 | Caliper Technologies Corporation | Controlled fluid transport in microfabricated polymeric substrates |
US5800999A (en) | 1996-12-16 | 1998-09-01 | Tropix, Inc. | Dioxetane-precursor-labeled probes and detection assays employing the same |
WO1998049548A1 (en) | 1997-04-25 | 1998-11-05 | Caliper Technologies Corporation | Microfluidic devices incorporating improved channel geometries |
US6159693A (en) | 1998-03-13 | 2000-12-12 | Promega Corporation | Nucleic acid detection |
WO2002072889A2 (en) | 2001-01-12 | 2002-09-19 | Applera Corporation | Methods and compositions for microarray control |
US20070015170A1 (en) * | 2005-07-12 | 2007-01-18 | Oy Jurilab Ltd | Method and kit for detecting a risk of coronary heart disease |
RU2322193C1 (ru) | 2006-12-04 | 2008-04-20 | Федеральное государственное учреждение "Учебно-научный медицинский центр" Управления делами Президента Российской Федерации | Способ оценки генетического риска сердечно-сосудистых заболеваний у спортсменов |
WO2008102380A1 (en) * | 2007-02-21 | 2008-08-28 | Decode Genetics Ehf | Genetic susceptibility variants associated with cardiovascular disease |
US7883851B2 (en) | 2007-05-02 | 2011-02-08 | Board Of Regents, The University Of Texas System | Common allele on chromosome 9 associated with coronary heart disease |
-
2009
- 2009-06-09 ES ES09162329.8T patent/ES2623633T3/es active Active
- 2009-06-09 EP EP09162329.8A patent/EP2264183B1/en not_active Not-in-force
- 2009-06-09 PT PT91623298T patent/PT2264183T/pt unknown
-
2010
- 2010-06-09 AR ARP100102016A patent/AR077026A1/es unknown
- 2010-06-09 UY UY0001032698A patent/UY32698A/es unknown
- 2010-06-09 US US13/377,216 patent/US9957565B2/en active Active
- 2010-06-09 RU RU2011154171/15A patent/RU2524659C2/ru not_active IP Right Cessation
- 2010-06-09 MX MX2011013243A patent/MX2011013243A/es active IP Right Grant
- 2010-06-09 BR BRPI1013082A patent/BRPI1013082A2/pt not_active IP Right Cessation
- 2010-06-09 ES ES10725412.0T patent/ES2627446T3/es active Active
- 2010-06-09 EP EP10725412.0A patent/EP2440674B1/en not_active Not-in-force
- 2010-06-09 CA CA2764693A patent/CA2764693C/en active Active
- 2010-06-09 PE PE2011002069A patent/PE20121029A1/es not_active Application Discontinuation
- 2010-06-09 PT PT107254120T patent/PT2440674T/pt unknown
- 2010-06-09 WO PCT/EP2010/058064 patent/WO2010142713A1/en active Application Filing
- 2010-06-09 AU AU2010257482A patent/AU2010257482B2/en not_active Ceased
-
2011
- 2011-12-09 CL CL2011003129A patent/CL2011003129A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
ES2627446T3 (es) | 2017-07-28 |
UY32698A (es) | 2010-11-30 |
PT2440674T (pt) | 2017-05-23 |
ES2623633T3 (es) | 2017-07-11 |
MX2011013243A (es) | 2012-04-10 |
PT2264183T (pt) | 2017-03-14 |
US9957565B2 (en) | 2018-05-01 |
AU2010257482B2 (en) | 2014-01-23 |
RU2524659C2 (ru) | 2014-07-27 |
CA2764693C (en) | 2017-07-11 |
EP2264183B1 (en) | 2016-12-07 |
EP2264183A1 (en) | 2010-12-22 |
EP2440674B1 (en) | 2017-04-05 |
US20120141450A1 (en) | 2012-06-07 |
BRPI1013082A2 (pt) | 2016-07-26 |
WO2010142713A1 (en) | 2010-12-16 |
PE20121029A1 (es) | 2012-08-09 |
EP2440674A1 (en) | 2012-04-18 |
AR077026A1 (es) | 2011-07-27 |
CA2764693A1 (en) | 2010-12-16 |
AU2010257482A1 (en) | 2012-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2011003129A1 (es) | Procedimiento para determinar riesgo de padecer enfermedad cardiovascular que comprende determinar la presencia de polimorfismos de un solo nucleotido (snp) | |
SMT201500003B (it) | Nuovo derivato di fenilimidazolo come inibitore dell'enzima PDE10A | |
UA19305S (uk) | Халява до взуття | |
BRPI0815603A2 (pt) | Determinação de preço de item de conteúdo | |
EP2222220A4 (en) | TRIMETHYLAMINE COMPOUNDS AS A MEANS FOR PREDICTING THE RISK OF CARDIOVASCULAR DISEASES | |
SG196776A1 (en) | Quinazolinone, quinolone and related analogs as sirtuin modulators | |
BRPI0909707A2 (pt) | Composição detergente que compreende lipase. | |
BR112012026536A2 (pt) | sistemas e métodos para predizer deficiência gastrointestinal | |
BRPI0910208A2 (pt) | umidificador em linha | |
FR2923491B1 (fr) | Utilisation de bacteries pour la production de sources de bioenergie | |
MX2010005960A (es) | Biomarcadores de braf. | |
BR112012012892A2 (pt) | misturas estabilizadas que contêm modificadores de fricção. | |
DK2417326T3 (da) | Rørsko | |
BR112014002856A2 (pt) | doença cardiovascular | |
BRPI1014355A2 (pt) | método para determinar umidificabilidade de uma zona de formação de solo em torno de um poço. | |
DK2345765T3 (da) | Vandbesparende skive | |
FI20075245A0 (fi) | Menetelmä oksidatiivisen metabolian arvioimiseksi | |
FI20075336A (fi) | Palveluun liittyvän pyynnön käsittely | |
BRPI0919100A2 (pt) | Inibição de corrosão. | |
BR112012012893A2 (pt) | misturas estabilizadoras que contêm modificadores de fricção. | |
WO2011146788A3 (en) | Methods of assessing a risk of developing necrotizing meningoencephalitis | |
ITRM20080037A1 (it) | Procedimento per la ultrapurificazione di alginati. | |
NL1034216A1 (nl) | Verbeterde structuur van Inline Skates. | |
ES1068308Y (es) | Zapatilla de baño | |
IL214347A0 (en) | Computer implemented system for providing musical message content |